tetano
Editor, Senior Moderator
J Gen Virol
. 2020 Nov 5.
doi: 10.1099/jgv.0.001513. Online ahead of print.
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression
Zhou Shen[SUP] 1 2 [/SUP], Guangxu Zhang[SUP] 2 [/SUP], Yilin Yang[SUP] 1 2 [/SUP], Mengxia Li[SUP] 1 2 [/SUP], Siqi Yang[SUP] 2 [/SUP], Guiqing Peng[SUP] 1 2 [/SUP]
Affiliations
Abstract
The emerging pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused social and economic disruption worldwide, infecting over 9.0 million people and killing over 469 000 by 24 June 2020. Unfortunately, no vaccine or antiviral drug that completely eliminates the transmissible disease coronavirus disease 2019 (COVID-19) has been developed to date. Given that coronavirus nonstructural protein 1 (nsp1) is a good target for attenuated vaccines, it is of great significance to explore the detailed characteristics of SARS-CoV-2 nsp1. Here, we first confirmed that SARS-CoV-2 nsp1 had a conserved function similar to that of SARS-CoV nsp1 in inhibiting host-protein synthesis and showed greater inhibition efficiency, as revealed by ribopuromycylation and Renilla luciferase (Rluc) reporter assays. Specifically, bioinformatics and biochemical experiments showed that by interacting with 40S ribosomal subunit, the lysine located at amino acid 164 (K164) was the key residue that enabled SARS-CoV-2 nsp1 to suppress host gene expression. Furthermore, as an inhibitor of host-protein expression, SARS-CoV-2 nsp1 contributed to cell-cycle arrest in G0/G1 phase, which might provide a favourable environment for virus production. Taken together, this research uncovered the detailed mechanism by which SARS-CoV-2 nsp1 K164 inhibited host gene expression, laying the foundation for the development of attenuated vaccines based on nsp1 modification.
Keywords: 40S ribosomal subunit; Host gene expression inhibition; K164; Nonstructural protein 1; Severe acute respiratory syndrome coronavirus 2.
. 2020 Nov 5.
doi: 10.1099/jgv.0.001513. Online ahead of print.
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression
Zhou Shen[SUP] 1 2 [/SUP], Guangxu Zhang[SUP] 2 [/SUP], Yilin Yang[SUP] 1 2 [/SUP], Mengxia Li[SUP] 1 2 [/SUP], Siqi Yang[SUP] 2 [/SUP], Guiqing Peng[SUP] 1 2 [/SUP]
Affiliations
- PMID: 33151142
- DOI: 10.1099/jgv.0.001513
Abstract
The emerging pathogen severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused social and economic disruption worldwide, infecting over 9.0 million people and killing over 469 000 by 24 June 2020. Unfortunately, no vaccine or antiviral drug that completely eliminates the transmissible disease coronavirus disease 2019 (COVID-19) has been developed to date. Given that coronavirus nonstructural protein 1 (nsp1) is a good target for attenuated vaccines, it is of great significance to explore the detailed characteristics of SARS-CoV-2 nsp1. Here, we first confirmed that SARS-CoV-2 nsp1 had a conserved function similar to that of SARS-CoV nsp1 in inhibiting host-protein synthesis and showed greater inhibition efficiency, as revealed by ribopuromycylation and Renilla luciferase (Rluc) reporter assays. Specifically, bioinformatics and biochemical experiments showed that by interacting with 40S ribosomal subunit, the lysine located at amino acid 164 (K164) was the key residue that enabled SARS-CoV-2 nsp1 to suppress host gene expression. Furthermore, as an inhibitor of host-protein expression, SARS-CoV-2 nsp1 contributed to cell-cycle arrest in G0/G1 phase, which might provide a favourable environment for virus production. Taken together, this research uncovered the detailed mechanism by which SARS-CoV-2 nsp1 K164 inhibited host gene expression, laying the foundation for the development of attenuated vaccines based on nsp1 modification.
Keywords: 40S ribosomal subunit; Host gene expression inhibition; K164; Nonstructural protein 1; Severe acute respiratory syndrome coronavirus 2.